Cargando…
Long-Term Outcome of Anti-Glomerular Basement Membrane Antibody Disease Treated with Immunoadsorption
BACKGROUND: Anti-glomerular basement membrane (GBM) antibody disease may lead to acute crescentic glomerulonephritis with poor renal prognosis. Current therapy favours plasma exchange (PE) for removal of pathogenic antibodies. Immunoadsorption (IAS) is superior to PE regarding efficiency of antibody...
Autores principales: | Biesenbach, Peter, Kain, Renate, Derfler, Kurt, Perkmann, Thomas, Soleiman, Afschin, Benharkou, Alexandra, Druml, Wilfred, Rees, Andrew, Säemann, Marcus D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117516/ https://www.ncbi.nlm.nih.gov/pubmed/25079220 http://dx.doi.org/10.1371/journal.pone.0103568 |
Ejemplares similares
-
Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis
por: Zhang, Yi-yan, et al.
Publicado: (2014) -
SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report
por: Winkler, Alexander, et al.
Publicado: (2021) -
Binding Truths: Seronegative Anti-Glomerular Basement Membrane Disease Mediated by IgM Anti-Glomerular Basement Membrane Antibodies
por: Antonelou, Marilina, et al.
Publicado: (2023) -
Clogging of the glomerular basement membrane
Publicado: (1982) -
Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
por: Lupinek, Christian, et al.
Publicado: (2017)